84 results
8-K
EX-99.1
BRSF
Brain Scientific Inc.
2 Nov 22
Daniel Cloutier, a Veteran Sales Executive, Joins Brain Scientific as Chief Revenue Officer
5:56pm
; lack of product diversification; volatility in the price of the company's raw materials; and the failure to implement the company's business plans
D
4npuqpofakvof
19 Jul 22
$5.15M in debt / options, sold $5.15M, 11 investors
12:59pm
DEF 14C
g4jdnlshb5ux61dl
5 Jul 22
Information statement
11:02am
PRE 14C
789mh ow8
24 Jun 22
Preliminary information
12:36pm
8-K
EX-99.1
dpdddms3 aa
15 Jun 22
Entry into a Material Definitive Agreement
11:15am
8-K
EX-10.1
mzigk
15 Jun 22
Entry into a Material Definitive Agreement
11:15am
8-K
EX-99.1
9bztxm859qs9badt51i
19 Apr 22
Regulation FD Disclosure
3:18pm
8-K
e5ap3bx65g 35ohpl
19 Apr 22
Regulation FD Disclosure
3:18pm
8-K
EX-10.1
gxxjlws
16 Feb 22
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-99.1
mc7an77cdas
13 Jan 22
Regulation FD Disclosure
5:28pm
8-K
cr7dd2k45r 58i
13 Jan 22
Regulation FD Disclosure
5:28pm
D
1rnc zu1om3toc4
13 Jan 22
$20M in debt / options, sold $9.66M, 13 investors
4:33pm
8-K
EX-10.1
8gej6y4h4uqd4nihdcsz
28 Dec 21
Entry into a Material Definitive Agreement
4:18pm
8-K/A
EX-99.2
ic7e32fjw inprvsj
15 Dec 21
Audited Consolidated Financial Statements
10:49am